Drug Discovery
Expanded capabilities in company’s Immunogenicity and Immuno-oncology QSP Simulators broaden applicability for addressing safety and efficacy challenges
| 2 min read
Industry-approved fluidic-free standard for label-free molecular interaction analysis
| 1 min read
New applications also provide a boost for the technique's possible use in subcellular characterization
| 4 min read
Demonstrating the novel technique on prexersatib, research team achieves a fully automated six-step synthesis with 65 percent isolated yield within 32 hours
| 3 min read
Understanding your digital integration requirements
| 1 min read
Funding will accelerate development of the company’s AI-powered antibody drug discovery technology, focused on identifying new therapeutics for cancer, heart, and lung diseases
| 2 min read
Vipergen’s Cellular Binder Trap Enrichment® (cBTE) technology provides a robust system to accelerate and improve drug discovery
| 3 min read
Through end-to-end automation, the company’s unique technology platform rapidly delivers reliable, reproducible, and fully auditable datasets
| 2 min read
Collaboration combines Sosei Heptares’ leading structure-based drug design platform with Metrion Biosciences’ ion channel expertise
| 2 min read
